Related Experiment Videos
Intrinsic and extrinsic pathomechanisms in vitiligo
1Service de Dermatologie, Hôpital Saint André and Laboratoire de Pathologie Moléculaire et Thérapie Génique, Université Victor Segalen, Bordeaux II, France. alain.taieb@dermatol.u-bordeaux2.fr
Pigment Cell Research
|October 21, 2000
Summary
Vitiligo involves melanocyte loss, with nonsegmental vitiligo (NSV) linked to redox imbalance and immune response, while segmental vitiligo (SV) may stem from developmental factors. Both forms highlight complex skin depigmentation mechanisms.
Area of Science:
- Dermatology
- Immunology
- Genetics
Background:
- Vitiligo is an acquired hypopigmentation disorder characterized by melanocyte loss.
- It presents as focal/segmental vitiligo (SV) or generalized nonsegmental vitiligo (NSV).
- NSV pathogenesis involves impaired redox status of the epidermal melanin unit, triggering immune responses.
Discussion:
- SV pathogenesis may involve mosaic developmental predisposition, with similar mechanisms acting on a smaller scale.
- Keratinocytes, beyond melanocytes, likely play a role in vitiligo.
- Autoimmune responses, including autoantibodies and cytotoxic T cells, contribute to vitiligo vulgaris self-perpetuation.
Key Insights:
- Melanocyte loss is central to vitiligo, affecting epidermal and follicular reservoirs.
- Redox imbalance is a key factor in NSV, potentially driving autoimmune reactions.
- Autologous melanocyte engraftment is less successful in NSV, particularly in trauma-prone areas.
Outlook:
- Further research is needed on pathological staging, clinical scoring, and eliciting factors in vitiligo.
- Genetic studies in vitiligo-prone families and associated genetic disorders are crucial.
- Understanding the interplay between melanocytes, keratinocytes, and the immune system is essential for future treatments.